Indoco Remedies receives USFDA approval to market generic Lacosamide oral solution for epilepsy treatment. Manufactured in ...

New Delhi, Jan 30 (PTI) Indoco Remedies Ltd on Friday said it has received approval from the US health regulator to market its generic version of Lacosamide oral solution used in the treatment of ...

Indoco Remedies announced final approval of the Company's Abbreviated New Drug Application (ANDA) for Lacosamide Oral Solution USP, 10 mg/mL, to market, a generic equivalent to the reference listed ...

Abstract: Integrating prior knowledge of neurophysiology into neural network architecture enhances the performance of emotion decoding. While numerous techniques emphasize learning spatial and ...

Two minutes. That's how long two-year-old Briar Curtis's heart stopped during a severe seizure in April 2025. Since birth and before, Briar had been sick. Her heart rate in the womb was high and ...

Epilepsy is one of the most common neurological disorders in the world. According to the World Health Organization, around 50 ...

New study suggests that an experimental peptide developed at the Hebrew University may reduce recurring seizures and support ...

Xenon Pharmaceuticals Inc. Phase 3 X-TOLE2 topline data for azetukalner in FOS expected March 2026 followed by anticipated NDA submission in H2 2026. Five additional Phase 3 azetu ...

Accurate localization of the EZ is crucial and is typically achieved through comprehensive presurgical approaches such as seizure semiology interpretation, electroencephalography (EEG), magnetic ...

LISLE, IL, UNITED STATES, January 12, 2026 /EINPresswire.com/ -- OWP Pharmaceuticals today announced commercial product ...

NeuroPace, Inc. (Nasdaq: NPCE), a medical device company focused on transforming the lives of people living with epilepsy, ...